A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Filters
Prostate Cancer and Prostate Cancer Stem Cells
[chapter]
2015
Principles of Stem Cell Biology and Cancer
The TE forms placental tissue and membranes, while the Principles of Stem Cell Biology and Cancer: Future Applications and Therapeutics, First Edition. Edited by Tarik Regad, Thomas J. ...
Some abnormalities enriched in hESC cultures are also found in tumours and might therefore carry a higher risk of inducing cancer-like changes. ...
It is of note that this will deprive the host of any means of immune detection, should such cells carry abnormalities that could cause cancer. ...
doi:10.1002/9781118670613.ch10
fatcat:hcjzvvzecjfl5cj4hphekuzeou
Prostate cancer
2003
British Journal of Cancer
Is there someone whom you want to give a generous (about d100) Christmas or birthday present to who treats prostate cancer? ...
Of course, many of the top names in prostate cancer do live and work in California and have contributed chapters. ...
doi:10.1038/sj.bjc.6600962
pmcid:PMC2377152
fatcat:fqhhifswa5cllhq2iqx23yu7gu
Prostatic cancer
1976
BMJ (Clinical Research Edition)
GILLIAN TURNER University Department of Obstetrics and Gynaecology, Bristol Maternity Hospital, Bristol Prostatic cancer SIR,-In your leading article on this subject (28 August, p 490) you did not mention ...
I write to make a plea for continued screening for breast cancer. ...
doi:10.1136/bmj.2.6041.942-b
pmid:974677
pmcid:PMC1688449
fatcat:grlrxlao4jaynjcou76axcue7y
Prostate cancer
2016
Salud Pública de México
salud pública de méxico / vol. 58, no. 2, marzo-abril de 2016 Prostate cancer Artículo especiAl P rostate cancer (PC) is the most common cancer and the leading cause of cancer death in men over 50 y in ...
In 2015, 41 210 cancer deaths are expected among men, 6 801 of which will be from PC. 1 Prostate-specific antigen (PSA) has been applied as a useful marker for the early diagnosis and monitoring of PC. ...
In 2009, the American group PLCO (Prostate, Lung, Colorectal and Ovarian Screening Trial) and the European group ERSPC (European Randomized Study on Screening for Prostate Cancer) separately published ...
doi:10.21149/spm.v58i2.7797
fatcat:upwoct4jx5gyjf6aygkpwzjuni
Prostate Cancer
2007
Journal of Urology
Conclusions: The burden of prostate cancer in the United States is considerable and it appears to have markedly increased in the prostate specific antigen era. ...
Finally, the total medical expenditure for prostate cancer treatment was $1.3 billion in 2000, which represents a 30% increase over the total expenditure for 1994. ...
Bradley et al queried a population based cohort of prostate cancer survivors and age matched controls, and found that men with prostate cancer were 10% less likely to be working 6 months after a prostate ...
doi:10.1016/j.juro.2007.01.121
pmid:17509282
fatcat:o5ki3f4owvfolekw7r5aguwadu
Prostate Cancer
1983
British Journal of Cancer
For each registry the numbers of cancers per Cancer Incidence in 5 Continents, Vol. IV (Eds J. WATERHOUSE, C. MUIR, K. SHANMUGARATNAM and J. ...
This volume contains detailed statistics of cancer incidence from eighty-one cancer registers covering various countries or territories in all parts of the world. ...
doi:10.1038/bjc.1983.121
pmcid:PMC2011393
fatcat:nmtmhmu3rfal7g7753ot3z424i
Prostate cancer
2014
Oncoimmunology
Prostate cancer: Important steps and considerations in the design of therapeutic vaccines. ...
Prostate cancer Stephanie We have recently demonstrated the ability of a prostatic acid phosphatase (PAP)-derived 15-mer peptide (PAP-114) to reduce the growth of established TRAMP C1 tumors in a preclinical ...
doi:10.4161/onci.28049
pmid:25340006
pmcid:PMC4203569
fatcat:rscmdrcuqvashmtasktt4jpkk4
Prostate Cancer
2010
The Journal of the National Comprehensive Cancer Network
The Early Prostate Cancer (EPC) trial was the largest prostate cancer trial to date and evaluated bicalutamide, 150 mg daily, as adjuvant therapy in 8113 patients with prostate cancer who were managed ...
Algorithms Initial Prostate Cancer Diagnosis Initial suspicion of prostate cancer is based on an abnormal DRE or elevated PSA level. ...
doi:10.6004/jnccn.2010.0012
pmid:20141676
fatcat:gcy77t7arrayxn7vqatwdz2btu
Prostate Cancer
[chapter]
2017
PET/MR Imaging
cancer
• Treatment related adverse effects
Personalized screening schedule
• If PSA less than population median for age
then consider not re-screening at all or re-
screen after 5 years
• ...
100
2001 2002
2004
2006
2008
2010
Year
40 to 49
50 to 59
60 to 69
70 to 79
80 to 99
OUTLINE
• PSA screening controversy
• How to use PSA more effectively
• Treatment of localized prostate ...
doi:10.1007/978-3-319-65106-4_86
fatcat:axfudoja3nb4tat7etrtjbwl4e
Prostatic cancer
1976
BMJ (Clinical Research Edition)
Prostatic cancer
If the proposed clinical trials for localised prostatic carcinoma are to yield meaningful results, then detailed investigation to fulfil the TNM requirements concern over this trap ...
E P N O'DONOGHUE
G D CHISHOLM
St Peter's Group of Hospitals
and Hammersmith Hospital,
London
I Bailar, J C, III, and Byar, D C, Cancer, 1970, 26, 257.
2 Blackard, C E, Cancer Chemotherapy Reports ...
doi:10.1136/bmj.2.6047.1324-e
pmid:1000217
pmcid:PMC1689962
fatcat:q7mqafbfzvcfjeiuie3w7nh5dy
Prostate cancer
2016
Nursing Standard
developing prostate cancer, see
Guideline for Klinefelter Syndrome and Cancer. ...
Drugs The inhibitors of 5-alpha-reductase, i.e. finasteride and dutasteride, reduce the risk for prostate cancer by 20-25%, see Prostate Cancer Study Results. ...
doi:10.7748/ns.30.40.17.s20
pmid:27275890
fatcat:yo5nnkdnnfb5vauntmrxigvo4a
Prostate Cancer
2011
The Scientific World Journal
and management of patients with prostate cancer remain enigmatic. ...
In this Prostate Cancer special issue, our expert authors present and examine clinically relevant topics and look ahead to future research. ...
Since the introduction of PSA-based prostate cancer screening, the age-adjusted mortality rate from prostate cancer has decreased approximately 40% in the U.S. ...
doi:10.1100/tsw.2011.79
pmid:21479346
pmcid:PMC5719996
fatcat:eip2nanskbeodhhb3nss74it5i
Prostate Cancer
1981
Journal of Clinical Pathology
In the event the workshop concentrated on the role of hormones and steroid receptors in the development and control of prostate cancer. ...
cancer. ...
doi:10.1136/jcp.34.6.691-b
fatcat:dobxcqoegrhg3bkvdu7umuty3a
Prostate cancer
1991
Disease-a-month
PROSTATE CANCER
ABSTRACT.— Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths. ...
to prostate cancer. ...
doi:10.1016/0011-5029(91)90004-u
pmid:2019219
fatcat:ospgwp2thzfcjkmbyxmxqrqfda
Prostatic cancer
1977
BMJ (Clinical Research Edition)
It is a depressing fact that only 100% of the currently available antitumour drugs have been adequately tested in prostatic cancer.3 4 Such little experience with chemotherapy in prostatic cancer is regrettable ...
In our opinion any logical trial aimed at improving the survival time in prostatic cancer should compare local or regional techniques such as surgery or radiotherapy with local therapy plus systemic therapy ...
doi:10.1136/bmj.1.6053.105-b
pmid:556675
pmcid:PMC1604033
fatcat:fqu4qd6rfzabvn72qypzdslxbq
« Previous
Showing results 1 — 15 out of 41,837 results